APIXAGET 2.5MG TABLET

Apixaget 2.5mg Tablet contains the active ingredient Apixaban, which is an anticoagulant medication belonging to the class of direct oral anticoagulants (DOACs). It works by inhibiting specific blood clotting factors, preventing the formation of blood clots. Apixaget is used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation and to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone hip or knee replacement surgery.

Uses:

1. Atrial Fibrillation (AFib): Apixaget 2.5mg Tablet is prescribed for patients with non-valvular atrial fibrillation (AFib) to reduce the risk of stroke and systemic embolism, particularly in those with additional risk factors for blood clot formation.
2. Deep Vein Thrombosis (DVT) Prevention and Treatment: It is used for the prevention and treatment of deep vein thrombosis in patients who have undergone hip or knee replacement surgery.
3. Pulmonary Embolism (PE) Prevention: Apixaget may also be used to prevent pulmonary embolism, a potentially life-threatening condition in which blood clots travel to the lungs, in patients who have undergone hip or knee replacement surgery.

Side Effects:

While Apixaget 2.5mg Tablet is generally well-tolerated, it may cause some side effects in certain individuals. Common side effects may include:

1. Bleeding: As an anticoagulant, the most significant side effect of Apixaget is an increased risk of bleeding, including nosebleeds, bruising, and gastrointestinal bleeding.
2. Fatigue: Some patients may experience mild fatigue or weakness.
3. Nausea: A small number of individuals may experience mild nausea.
4. Headache: Rarely, headaches may be reported.

When Not to Use:

1. Hypersensitivity: If you have a known allergy or hypersensitivity to Apixaban or any other components of the tablet, avoid using Apixaget 2.5mg.
2. Severe Liver Dysfunction: Individuals with severe liver impairment should exercise caution and consult their doctor before using this medication, as it may require dosage adjustment.
3. Pregnancy and Breastfeeding: The safety of Apixaget during pregnancy and breastfeeding has not been established. Consult your healthcare provider before using this medication if you are pregnant or breastfeeding.
4. Children: Apixaget is not recommended for use in children or adolescents.
5. Active Bleeding: Avoid using Apixaget in patients with active major bleeding or a history of serious bleeding disorders.

Always take Apixaget 2.5mg Tablet as prescribed by your doctor. Inform your healthcare provider about any existing medical conditions and other medications you may be taking to prevent potential interactions. If you experience severe or persistent side effects, discontinue the medication and seek medical attention. Do not alter the dosage or stop the medication without consulting your doctor. Regular monitoring of blood parameters may be necessary during treatment.